Effect of Ipratropium Bromide and Tiotropium Bromide in Patients Suffers From Chronic Obstructive Pulmonary Disease (COPD), Attending in Tertiary Care Hospital, at S.K.M.C.H., Muzaffarpur
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 9
Abstract
Objective: The aim of present study was to compare the effect of 9 months treatment with inhaled Ipratropium bromide and inhaled Tiotropium bromide on airflow obstruction and symptoms, by assessing clinical improvement as well as alteration on pulmonary function tests in cases of mild to moderate chronic obstructive pulmonary disease (COPD). Material and Methods: A total of 64 patients of 25-65 year of age group of either sex suffered from mild to moderate chronic obstructive pulmonary Disease (COPD) diagnosed by clinical examination, Pulmonary function tests (FEV1, FEV1/FVC, PEFR, FVC by spirometry) and Routine investigation (CBC, Blood sugar, LFT, KFT, Arterial Blood gas analysis, X-ray chest and ECG) were included in the study. All the patient were randomized into two treatment group, with equal proportion of patients (Group A-32 patients and Group- B 32 patients) on the basis of age, sex, severity of disease and smoking habits. Group A patients received inhalation of Ipratropium bromide 40 micrograms by 6 hourly daily for 9 months and the group B patients received inhalation of Tiotropium bromide 18 micrograms by once daily for 9 months. All the patients were followed up at 1 month, 3 months, 6 month and 9 months interval to monitor and improvements in clinical status, Pulmonary function tests, frequency of acute exacerbation and need of additional drugs. Any adverse effect of drugs and any changes in laboratory parameter were noted. Results: Inhaled Tiotropium bromide was more effective in compare to Ipratropium bromide in patients with mild to moderate cases of COPD And Both drugs were equally effective in clinical improvements over the period of a months. Conclusion: It is suggested that Tiotropium bromide (18 micrograms OD) inhalation could be more suitable and acceptable by the patients of COPD due to its longer duration of action and it is more effectiveness as compared to Ipratropium bromide (40 micrograms QID inhalation).
Authors and Affiliations
Dr Deepak Kumar
Bacteriological profile and antibiotic resistance pattern of isolates from neonatal septicemia patients in tertiary care hospital central India
Background: Neonatal septicemia still a major cause of mortality and morbidity worldwide. Blood culture is the main stay in the diagnosis of septicemia. Emergence of drug resistant bacterial strains is a major problem in...
Cytological Diagnosis of Thyroid Lesions with Age & Sex Incidence in a Rural Teaching Hospital
Diseases of the thyroid gland are very common and comprise a wide spectrum of disorders. Fine needle aspiration is a well-established diagnostic tool for the evaluation of palpable thyroid swellings. FNAC bridges the gap...
Mixed Connective Tissue Disorder Presenting As Eclampsia In A Primigravida: A Case Report
A 23 year old primigravida was diagnosed as a case of Mixed Connective Tissue Disorder (MCTD) after she presented with petechie, synovitis and raynauds phenomenon in the first trimester of pregnancy and was treated with...
Effect of Dexmeditomidine and Clonidine as Spinal Adjuvant in TURP – A Comparative Study
Background: The standard anaesthetic technique for TURP (Transurethral Resection of Prostate) is subarachnoid block. Bupivacaine is the local anaesthetic drug used to achieve the subarachnoid block. Adjuvants are used to...
Clinical Profile of Mortality due to fever with Thrombocytopenia during an Epidemic
Introduction: Many of the acute infective diseases which present as febrile thrombocytopenia during an epidemic have overlapping clinical profile and many of them may not have a definite diagnosis even at the time of pat...